Series IIB Financing was supported by existing and new investors in South Korea.Proceeds strengthen Cerecin’s operating position to advance the clinical studies of CER-0001 in migraine and infantile spasms.New funds will also be used to build Cerecin’s pipeline and advance plans for a pivotal trial in Alzheimer’s disease. SINGAPORE and DENVER, Sept. 28, 2022 (GLOBE NEWSWIRE) -- Cerecin Inc., a clinical-stage biotechnology company pioneering innovative neurotherapeutics, today announced it has su
[Ad hoc announcement pursuant to Art. 53 LR] This press release is also available in Français (pdf) and Deutsch (pdf) ............. Nestlé appoints Lisa Gibby as Chief Communications Officer Vevey, September 22, 2022 The Nestlé Board of Directors has appointed Lisa Gibby as Deputy Executive Vice President and Chief Communications Officer and as a member of the Executive Board of Nestlé S.A., effective January 1, 2023. In her role, Lisa Gibby will oversee the company’s Corporate Communications fu
GIS vs. NSRGY: Which Stock Is the Better Value Option?